Introduction of Drug Exclusivity in China Marks New Era for Drug Innovation
Summary
China is shifting from a generic manufacturing base to a global hub for new drug innovation. This transition is increasing the need to strengthen the patent protection system, and data exclusivity will finally be introduced in China soon.Table of Contents
- Key findings
- Transition from generics to innovative development
- Progression of IP protection in China
- Disclaimer
